Dataset Information


Challenges in using ¹?F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer.

ABSTRACT: BACKGROUND:The best method of identifying regions within pancreatic tumours that might benefit from an increased radiotherapy dose is not known. We investigated the utility of pre-treatment FDG-PET in predicting the spatial distribution of residual metabolic activity following chemoradiotherapy (CRT) in locally advanced pancreatic cancer (LAPC). METHODS:17 patients had FDG-PET/CT scans at baseline and six weeks post-CRT. Tumour segmentation was performed at 40% and 50% of SUVmax at baseline and 60%, 70%, 80% and 90% post-CRT. FDG-PET scans were non-rigidly registered to the radiotherapy planning CT using the CT component of the FDG-PET/CT. Percentage overlap of the post-CRT volumes with the pre-CRT volumes with one another and the gross tumour volume (GTV) was calculated. RESULTS:SUVmax decreased during CRT (median pre- 8.0 and post- 3.6, p?

PROVIDER: S-EPMC4078370 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6306774 | BioStudies
2018-01-01 | S-EPMC5944828 | BioStudies
| S-EPMC5893524 | BioStudies
| S-EPMC6704108 | BioStudies
| S-EPMC7371172 | BioStudies
| S-EPMC7908760 | BioStudies
| S-EPMC5228298 | BioStudies
| S-EPMC5099292 | BioStudies
| S-EPMC6114038 | BioStudies
| S-EPMC4693609 | BioStudies